%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
The FY2024 (Mar) proxy of Roivant Sciences names 25 peer companies for pay. Among Roivant Sciences and these peers, CEO pay was the highest of 9 and total shareholder return was 3rd highest of 9.
1st highest of 9in Roivant Sciences and its pay peers, FY2024 (Mar) by CEO pay:
$8.5M$163.3M
3rd highest of 9in Roivant Sciences and its pay peers, FY2024 (Mar) by total shareholder return:
$58$401
Pay peer group, FY2024 (Mar) proxy
| United Therapeutics | ||
| Incyte | ||
| BridgeBio Pharma | ||
| Jazz Pharmaceuticals | ||
| Ionis Pharmaceuticals | ||
| Halozyme Therapeutics | ||
| Revolution Medicines | ||
| Neurocrine Biosciences | ||
| ACADIA Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| Amicus Therapeutics, Inc. | Not disclosed | Not disclosed |
| Apellis Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Arcutis Biotherapeutics, Inc. | Not disclosed | Not disclosed |
| Ascendis Pharma, Inc. | Not disclosed | Not disclosed |
| Axsome Therapeutics | Not disclosed | Not disclosed |
| Blueprint Medicines Corporation | Not disclosed | Not disclosed |
| CRISPR Therapeutics, Inc. | Not disclosed | Not disclosed |
| Cerevel Therapeutics Holdings, Inc. | Not disclosed | Not disclosed |
| Denali Therapeutics Inc. | Not disclosed | Not disclosed |
| Exelixis | Not disclosed | Not disclosed |
| ImmunoGen, Inc. | Not disclosed | Not disclosed |
| Intra-Cellular Therapies, Inc. | Not disclosed | Not disclosed |
| Karuna Therapeutics, Inc. | Not disclosed | Not disclosed |
| MoonLake Immunotherapeutics | Not disclosed | Not disclosed |
| Sarepta Therapeutics, Inc. | Not disclosed | Not disclosed |
| Vaxcyte, Inc. | Not disclosed | Not disclosed |
25 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.